Chinese | English | Français | Deutsch | Vietnamese

Company
Jointease w/UC-II
Life Flower
NotoGinseng
InnerPure
LiverPure
Sleepure
Hot Plants for Her
Mans's Favorite
Anti-Aginag Product
Blood Circulation
Bone Health
Vitamins & Minerals
Beauty & Health
contact Us
Onlien Shopping

Important Information:

Cerebrovascular Disorders

Thrombosis, embolism, and hemorrhage are the three major causes of cerebrovascular accident (CVA). Thrombosis usually occurs in middle-aged and elderly people. CVA occurs when blood vessels are obstructed. Typically, the main site of the obstruction is the extra-cerebral or intra-cerebral vessels.

Embolism can occur at any age, especially among patients with a history of rheumatic heart disease, endocarditis, post transmatic valvular disease, myocardial fibrillation, and other cardiac arrhythmias, or after open-heart surgery. Usually it occurs in the left middle cerebral arteries.

Hemorrhage also occurs in middle-aged and elderly people, sudden rupture of a cerebral artery from hypertension or aneurysms will cause hemorrhage and endanger one’s life.

Clinical Pharmacology of Breviscapini®

Breviscapini® is formulated by using the effective elements extracted from an herb named Erigeron Breviscapinus, and it has been prescribed for centuries to treat cerebrovascular disorders. Many patients get a second chance of life after taking Breviscapini™ when they have cerebrovascular complications. Thus, named LIFEFLOWER™

Breviscapini® has been proven in many pharmacological studies . It has conspicuous biological activities that increase cerebrovascular blood flow. Other functions such as:
1. Raises the permeability of blood-brain barrier;
2. Increases nutritional blood flow of myocardium;
3. Raises immune function of cellulose dissolution;
4. Increases peripheral coronary blood flow; and
5. Helps maintain a healthy brain.


Whole plant extract from Erigeron breviscapus, a native plant found only in the mountains over elevation of 3000m.

Over 10 million clinical cases (aged 30-85 years) have proved that Breviscapini® is highly effective in cerebrovascular disorders, including cerebral embolism, and blood-brain barrier diseases, It is important to note that 82% clinical cases reported improvement in their state of cerebrovascular diseases. *

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, cure, treat, or prevent any disease.

<< Previous    |   Next >>

©2004-2007 Farlong® Pharmaceutical. ­º­¶ Home Page Email us